Moomoo AI 已提取核心信息
AbbVie Inc. officer Perry C Siatias is set to sell 13,753 shares of the company's common stock on February 23, 2024, according to a recent filing. The shares, valued at approximately $2.44 million, were acquired on the same date through the exercise of stock options. The transaction involved a cash payment made by Siatias to the issuer. This planned sale follows a previous transaction in the past three months where Siatias sold 2,919 shares, generating gross proceeds of $496,230.
AbbVie Inc. officer Perry C Siatias is set to sell 13,753 shares of the company's common stock on February 23, 2024, according to a recent filing. The shares, valued at approximately $2.44 million, were acquired on the same date through the exercise of stock options. The transaction involved a cash payment made by Siatias to the issuer. This planned sale follows a previous transaction in the past three months where Siatias sold 2,919 shares, generating gross proceeds of $496,230.
根据最近的一份文件，艾伯维公司高管佩里·西亚蒂亚斯定于2024年2月23日出售该公司13,753股普通股。这些股票价值约244万美元，于同日通过行使股票期权收购。该交易涉及Siatias向发行人支付的现金。此次计划出售是在过去三个月中进行的一笔交易之后进行的，当时西亚蒂亚斯出售了2,919股股票，总收益为496,230美元。
根据最近的一份文件，艾伯维公司高管佩里·西亚蒂亚斯定于2024年2月23日出售该公司13,753股普通股。这些股票价值约244万美元，于同日通过行使股票期权收购。该交易涉及Siatias向发行人支付的现金。此次计划出售是在过去三个月中进行的一笔交易之后进行的，当时西亚蒂亚斯出售了2,919股股票，总收益为496,230美元。
有用
没用
该公告为独立文件：